Duffy, J., Rider, A., Loneman, D., Thakkar, D., Mullen, G., Newton, G., Alvarado, R., Ku, B., Wang, S., Russell, V., Chen, Y., Townsend, J., Martin, H., Harkins, S., Cho, C., Au-Yeung, R., Chadburn, A., Cheng, C. L., Czader, M., Mason, E. F., Evans, A., Fedoriw, Y., Koff, J., Naresh, K. N., Ondrejka, S., Pedersen, M., Soumerai, J., Ott, C., García-Beltrán, W., Dave, S., Louissaint, A. (2025). ALK+ LBCL and PBL share a similar plasmablastic transcriptional identity but show divergent signaling dependencies and therapeutic vulnerabilities. Blood. https://doi.org/10.1182/blood-2025-51